Precursor Condition
Cervical Intraepithelial Neoplasia
CI-CAN-00000664CINExplore in graph →
Precursor45 active trials
Loading cancer entity…
Precursor Condition
CI-CAN-00000664CINExplore in graph →
Clinical trials
316 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.
| NCT | Title | Status | Phase | Enrollment (n) | Sponsor | Countries | Last update | Source |
|---|---|---|---|---|---|---|---|---|
| NCT04073082 | Safety and Efficacy of Laser Therapy in Gynaecology | unknown | — | 300 | Juna d.o.o.INDUSTRY | 1 | Aug 30, 2019 | clinicaltrials |
| NCT03239223 | Study of Topical ABI-1968 in Subjects With Precancerous Cervical Lesions From Human Papillomavirus (HPV) Infection | completed | Phase 1 | 16 | Antiva BiosciencesINDUSTRY | 2 | Jul 10, 2019 | clinicaltrials |
| NCT02631863 |
| Aminolaevulinic Acid Photodynamic Therapy for HPV+ Low Grade Cervical Intraepithelial Neoplasia (LSIL;CIN1) |
| completed |
| Phase 2 |
| 60 |
| Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.INDUSTRY |
| 1 |
| Jul 8, 2019 |
| clinicaltrials |
| NCT02304770 | Aminolaevulinic Acid Photodynamic Therapy of Cervical Persistent HPV Infection and Cervical Neoplasia | completed | Phase 2 | 73 | Shanghai Fudan-Zhangjiang Bio-Pharmaceutical Co., Ltd.INDUSTRY | 1 | Jun 12, 2019 | clinicaltrials |
| NCT03975127 | Cervical Cytology - Do SMS Reminders Increase Participation in the Cervical Screening Programme? | unknown | N/A | 50,000 | NHS Greater Glasgow and ClydeOTHER | 0 | Jun 5, 2019 | clinicaltrials |
| NCT03870113 | DC Vaccines Targeting HPV16/18 E6/E7 Protein to Regress CINI/CIN2 | unknown | Phase 1 | 80 | Shenzhen People's HospitalOTHER | 1 | Mar 14, 2019 | clinicaltrials |
| NCT03813576 | Acceptability and Efficacy of Self-sampling for Cervical Cancer Screening: A Pilot Study | unknown | N/A | 300 | National University Hospital, SingaporeOTHER | 0 | Jan 23, 2019 | clinicaltrials |
| NCT03206255 | Immuno-persistence Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls | completed | — | 940 | Jun ZhangOTHER | 1 | Jan 4, 2019 | clinicaltrials |
| NCT01544478 | V501 Safety and Efficacy Study in Japanese Women Aged 16 to 26 Years (V501-110) | completed | Phase 4 | 1,030 | Merck Sharp & Dohme LLCINDUSTRY | 0 | Nov 28, 2018 | clinicaltrials |
| NCT01131312 | Randomized Clinical Trial on Clinical Management of ASCUS and LSIL (ALTS) | completed | Phase 3 | 5,060 | National Cancer Institute (NCI)NIH | 1 | Nov 20, 2018 | clinicaltrials |
| NCT02814448 | An Innovative Treatment for Cervical Pre Cancer(CryoPen) | completed | N/A | 130 | The Cleveland ClinicOTHER | 2 | Nov 20, 2018 | clinicaltrials |
| NCT03745846 | A Efficacy and Safety Study of Composite Gel Containing Black Raspberry Extract in Removing HPV From Patients With Cervical Intraepithelial Neoplasia(CIN) After Cervical Conization | unknown | Phase 2 | 78 | Tianjin Medical University Cancer Institute and HospitalOTHER | 0 | Nov 19, 2018 | clinicaltrials |
| NCT02363088 | Can Text Reminders Improve Uptake of Cervical Screening? | completed | N/A | 14,597 | Sarah HufOTHER | 1 | Oct 25, 2018 | clinicaltrials |
| NCT01628432 | Effect of Salpingectomy During Conservative Hysterectomy(SALPINGOVA) | completed | N/A | 350 | University Hospital, ToursOTHER | 1 | Oct 22, 2018 | clinicaltrials |
| NCT02346227 | Impact of AV2 Antiviral Drug on the Treatment of HPV-associated Lesions of the Uterine Cervix(KINVAV) | completed | Phase 3 | 327 | Jean-Pierre Van geertruydenOTHER | 1 | Oct 12, 2018 | clinicaltrials |
| NCT01304524 | A Study of VGX-3100 DNA Vaccine With Electroporation in Patients With Cervical Intraepithelial Neoplasia Grade 2/3 or 3(HPV-003) | completed | Phase 2 | 167 | Inovio PharmaceuticalsINDUSTRY | 9 | Sep 7, 2018 | clinicaltrials |
| NCT02562508 | A Bridging Study of a Recombinant Human Papillomavirus 16/18 Bivalent Vaccine in Preadolescent Girls | completed | Phase 3 | 979 | Jun ZhangOTHER | 1 | Aug 16, 2018 | clinicaltrials |
| NCT02917746 | Imiquimod Treatment of High-grade CIN(TOPIC-3) | unknown | N/A | 120 | Maastricht University Medical CenterOTHER | 1 | Aug 16, 2018 | clinicaltrials |
| NCT02329171 | Imiquimod Treatment of CIN Lesions(TOPIC) | terminated | Phase 3 | 9 | Maastricht University Medical CenterOTHER | 1 | Aug 15, 2018 | clinicaltrials |
| NCT03469531 | Study of Nimotuzumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer | unknown | Phase 2 | 100 | Zhujiang HospitalOTHER | 1 | Aug 13, 2018 | clinicaltrials |
| NCT00988559 | Therapeutic Vaccination for Patients With HPV16+ Cervical Intraepithelial Neoplasia (CIN2/3) | completed | Phase 1 | 132 | Sidney Kimmel Comprehensive Cancer Center at Johns HopkinsOTHER | 1 | Jul 9, 2018 | clinicaltrials |
| NCT03005795 | Music and Colposcopy in Women With Cervical Dysplasia. | completed | N/A | 205 | Zydolab - Institute of Cytology and Immune CytochemistryOTHER | 1 | May 8, 2018 | clinicaltrials |
| NCT03141463 | Vvax001 Cancer Vaccine in (Pre) Malignant Cervical Lesions | completed | Phase 1 | 12 | University Medical Center GroningenOTHER | 1 | May 3, 2018 | clinicaltrials |
| NCT01145781 | Trial to Evaluate Single- and Double- Freeze Cryotherapy in the Prevention of Cervical Neoplasia | completed | N/A | 440 | Tata Memorial HospitalOTHER_GOV | 1 | May 1, 2018 | clinicaltrials |
| NCT00443313 | Human Papillomavirus (HPV) Testing to Improve Cervical Cancer Screening in the Mississippi Delta | completed | — | 664 | National Cancer Institute (NCI)NIH | 1 | Apr 5, 2018 | clinicaltrials |
| NCT01709773 | Focal Ablation of Cervical Precancer | completed | N/A | 20 | University of California, San FranciscoOTHER | 1 | Feb 20, 2018 | clinicaltrials |
| NCT02669459 | Imiquimod Treatment of Residual or Recurrent CIN Lesions: a Study Protocol(TopIC-2) | unknown | Phase 3 | 433 | Erasmus Medical CenterOTHER | 1 | Feb 6, 2018 | clinicaltrials |
| NCT03366493 | The Study of Folate Receptor-Mediated Staining Solution (FRD™) In Cervical Lesion Detection | unknown | Phase 3 | 200 | GY Highland Biotech LLCINDUSTRY | 1 | Dec 8, 2017 | clinicaltrials |
| NCT03143491 | Study of SOR007 Ointment for Cervical Intraepithelial Neoplasia (CIN) | withdrawn | Phase 2 | 0 | DFB Soria, LLCINDUSTRY | 0 | Oct 18, 2017 | clinicaltrials |
| NCT03293628 | Comparing Two Techniques of Haemostasis After Cervical Conization | completed | Phase 2 | 100 | Barretos Cancer HospitalOTHER | 1 | Sep 28, 2017 | clinicaltrials |
| NCT00081263 | Celecoxib in Treating Patients With Cervical Intraepithelial Neoplasia | completed | Phase 2 | 130 | Gynecologic Oncology GroupNETWORK | 1 | Sep 15, 2017 | clinicaltrials |
| NCT02139267 | Dose-finding, Safety Study of Plasmid DNA Therapeutic Vaccine to Treat Cervical Intraepithelial Neoplasia | completed | Phase 2 | 72 | Genexine, Inc.INDUSTRY | 1 | Jul 12, 2017 | clinicaltrials |
| NCT02596243 | Phase 2 Clinical Trial to Evaluate the Safety and Efficacy of Plasmid DNA Therapeutic Vaccine(GX-188E) | unknown | Phase 2 | 134 | Genexine, Inc.INDUSTRY | 3 | Jul 12, 2017 | clinicaltrials |
| NCT01058148 | A Comparison Study of Two Community Outreach-Based Approaches to Increase Participation of Women Living in the Mississippi Delta in Cervical Cancer Screening | completed | — | 400 | National Cancer Institute (NCI)NIH | 1 | Jul 2, 2017 | clinicaltrials |
| NCT02130323 | Topical Imiquimod vs. LEEP for Women With Carcinoma In-situ of the Cervix | completed | Phase 2 / Phase 3 | 22 | United States Naval Medical Center, San DiegoFED | 1 | Jun 27, 2017 | clinicaltrials |
| NCT02576158 | HPV Integration Testing for Cervical Cancer Screening | unknown | — | 12,000 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT02576262 | HPV Integration Testing for Human Papillomavirus-Positive Women | unknown | — | 1,200 | Huazhong University of Science and TechnologyOTHER | 1 | Jun 27, 2017 | clinicaltrials |
| NCT02629510 | The Efficacy of Tachosil® for Prevention of Hemorrhage After Loop Electrosurgical Excisional Procedure (LEEP)(TACO) | unknown | Phase 4 | 268 | Asan Medical CenterOTHER | 1 | May 31, 2017 | clinicaltrials |
| NCT00337818 | Human Papillomavirus (HPV) Vaccine Consistency and Non-inferiority Trial in Young Adult Women | completed | Phase 3 | 770 | GlaxoSmithKlineINDUSTRY | 1 | May 30, 2017 | clinicaltrials |
| NCT01345279 | Indirect Comparison Topotecan Cervical Carcinoma | completed | — | 1 | GlaxoSmithKlineINDUSTRY | 0 | May 30, 2017 | clinicaltrials |
| NCT00212381 | Oral Diindolylmethane (DIM) for the Treatment of Cervical Dysplasia | completed | Phase 3 | 62 | New York Presbyterian HospitalOTHER | 1 | Mar 29, 2017 | clinicaltrials |
| NCT02697175 | Video Colposcopy in Women With Dysplasia | completed | N/A | 275 | Zydolab - Institute of Cytology and Immune CytochemistryOTHER | 1 | Mar 27, 2017 | clinicaltrials |
| NCT02494310 | HRME: Screening for Cervical Cancer and Its Precursors in Low-Resource Settings(HRME-UH2) | completed | N/A | 200 | Barretos Cancer HospitalOTHER | 0 | Feb 3, 2017 | clinicaltrials |
| NCT01283763 | Topical Imiquimod Versus Conization to Treat Cervical Intraepithelial Neoplasia(ITIC2) | terminated | Phase 3 | 95 | Medical University of ViennaOTHER | 1 | Nov 1, 2016 | clinicaltrials |
| NCT02811367 | The HPV Self-test as a Test of Cure in Madagascar | completed | N/A | 117 | University Hospital, GenevaOTHER | 1 | Oct 17, 2016 | clinicaltrials |
| NCT02398916 | Music Listening to Reduce Pain and Anxiety During LEEP | completed | N/A | 150 | Chiang Mai UniversityOTHER | 1 | Aug 30, 2016 | clinicaltrials |
| NCT02368054 | Hemodynamic Stability of Bupivacaine With and Without Adrenaline for Paracervical Block for Cervical Conization(HSBAPCB) | completed | Phase 4 | 34 | Helse FonnaOTHER | 1 | Aug 19, 2016 | clinicaltrials |
| NCT02515162 | Fischer Cone Biopsy Excisor Versus Loop Excision Procedure for Conization | completed | N/A | 178 | Zydolab - Institute of Cytology and Immune CytochemistryOTHER | 1 | Aug 16, 2016 | clinicaltrials |
| NCT01022346 | A Study of RO5217790 in Participants With High Grade Cervical Intraepithelial Neoplasia (CIN) Associated With High Risk Human Papillomavirus (HR-HPV) Infection | completed | Phase 2 | 206 | Hoffmann-La RocheINDUSTRY | 6 | Aug 15, 2016 | clinicaltrials |
| NCT01116245 | An Assessment of an Attenuated Live Listeria Vaccine in CIN 2+(ADXS11-001) | terminated | Phase 2 | 81 | Advaxis, Inc.INDUSTRY | 1 | Jul 27, 2016 | clinicaltrials |
Data updated 23 days agoSource updated Aug 30, 2019source: clinicaltrials